Advertisement

Topics

TransForm Pharmaceuticals Incorporated Company Profile

21:23 EDT 18th June 2018 | BioPortfolio

Revolutionary Product Development Platform

We're TransForm Pharmaceuticals, a pre-IPO with impressive roots and significant funding, conceived to RADICALLY transform the process of pharmaceutical development. The way we see it - development is the product of creativity.

Location

610 Licoln Street
Waltham
MA
02451
United States of America

Contact

Phone: 781 926 8500
Fax: 781 890 7378


News Articles [559 Associated News Articles listed on BioPortfolio]

AirPlus International Selects Icertis to Transform Contracting Foundation, Speed Time to Revenue

Because contracts are foundational to commerce, the ICM platform is a core element of AirPlus' effort to transform its lead-to-cash process to more aggressively compete Read more...

GW files cannabis-based epilepsy drug in EU and US

GW Pharmaceuticals ended 2017 by filing its childhood epilepsy drug Epidiolex with regulators in the US and EU, setting up a potential launch for a drug that could transform the company's fortunes. E...

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

Company Profile for SPECTRUM PHARMACEUTICALS

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. S...

Innovation Hub in Denver will Look to “Transform Healthcare Delivery”

Rajiv LeventhalA team of innovators at the Aurora, Colo.-based UCHealth will be developing an innovation hub with the goal “to help transform healthcare delivery of the future,” officials said in ...

Critical Analysis: Sagent Pharmaceuticals

Sagent Pharmaceuticals and Lannett are both pharmaceuticals - nec companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analy...

Healthcare in 2040: How Robots could Transform the NHS

It’s 2040. You’re going about your business when you feel your wearable health monitor buzz. One of its sensors has detected something’s not quite right.... The post Healthcare in 2040: How Robo...

Discovery of immune cells able to defend against mutating viruses could transform vaccine developmen

(University of Exeter) Scientists have found immune cells can fight different strains of the same virus -- a discovery which could help transform vaccine development.

PubMed Articles [244 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.

Pharmaceuticals are found in freshwater ecosystems where even low concentrations in the range of ng Lmay affect aquatic organisms. In the current study, we investigated the effects of chronic exposure...

Clinical Trials [270 Associated Clinical Trials listed on BioPortfolio]

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

TRANSFORM-HF is a large-scale, pragmatic, randomized, unblinded clinical effectiveness study comparing torsemide versus furosemide as treatment for heart failure. Approximately 6,000 patie...

A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1630 Associated Companies listed on BioPortfolio]

TransForm Pharmaceuticals Incorporated

Revolutionary Product Development PlatformWe're TransForm Pharmaceuticals, a pre-IPO with impressive roots and significant funding, conceived to RADICALLY transform the process of pharmaceutical devel...

TransForm Pharmaceuticals, Inc.

TransForm Pharmaceuticals brings new value to products by reinventing the industry’s approach to form and formulation, with deep scientific expertise in form and formulation, state-of-art high-throu...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development, and commercialization of innovative medicines. A...

Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceut...

More Information about "TransForm Pharmaceuticals Incorporated" on BioPortfolio

We have published hundreds of TransForm Pharmaceuticals Incorporated news stories on BioPortfolio along with dozens of TransForm Pharmaceuticals Incorporated Clinical Trials and PubMed Articles about TransForm Pharmaceuticals Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TransForm Pharmaceuticals Incorporated Companies in our database. You can also find out about relevant TransForm Pharmaceuticals Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record